MET and neoplasm: In our study, we found that individual evaluation of MET and FGFR2 did not show significant differences between tumor and normal tissue samples, but combined assessment of both genes revealed significant amplification in tumor samples than normal tissue based on RNAseq preliminary data (Supplementary Figure S1).